Items where Author is "NL, Zaharan,"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article | Other
Number of items: 8.


NL, Zaharan, (2011) Irish Medicines Board safety warnings: do they affect prescribing rates in primary care? Pharmacoepidemiol Drug Saf, 20 (9). pp. 979-986.

NL, Zaharan, (2011) Statins and new-onset diabetes in the primary care population. Basic & Clinical Pharmacology & Toxicology, 109 (S1). p. 140.

WAH, Wan Md Adnan, and NL, Zaharan, (2011) Trends in co-prescribing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in Ireland. Br J Clin Pharmacol, 71 (3). pp. 458-466.

NL, Zaharan, (2010) Assessment of relationship between patient- reported compliance with medications and cardiovascular risk factors in Type 2 diabetes. Irish Journal of Medical Science, 179 (13). p. 526.

NL, Zaharan, (2009) Hypertension in Ireland: public awareness and doctors choice of therapy. pp. 413-417.

NL, Zaharan, (2008) Prevalence and awareness of blood pressure and its treatment among general public in Dublin. Pharmacoepidemiol Drug Saf, 17 (7). p. 749.


NL, Zaharan, (2013) Hyponatraemia predicts 1-year mortality in stable peritoneal dialysis patients. Oxford University Press.

NL, Zaharan, (2009) Beliefs about medicines affect adherence to medications. Springer.

This list was generated on Sun May 20 02:02:52 2018 MYT.